Compare IRWD & AVK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IRWD | AVK |
|---|---|---|
| Founded | 1998 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 251.8M | 559.4M |
| IPO Year | 2010 | N/A |
| Metric | IRWD | AVK |
|---|---|---|
| Price | $3.18 | $12.57 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $5.34 | N/A |
| AVG Volume (30 Days) | ★ 2.6M | 112.9K |
| Earning Date | 11-10-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.85% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.18 | N/A |
| Revenue | ★ $338,987,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.01 | N/A |
| P/E Ratio | $18.24 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.53 | $9.24 |
| 52 Week High | $4.78 | $12.16 |
| Indicator | IRWD | AVK |
|---|---|---|
| Relative Strength Index (RSI) | 48.55 | 52.84 |
| Support Level | $3.08 | $12.54 |
| Resistance Level | $3.35 | $12.70 |
| Average True Range (ATR) | 0.26 | 0.14 |
| MACD | -0.11 | 0.01 |
| Stochastic Oscillator | 12.99 | 67.94 |
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.
Advent Convertible & Income Fund is a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The Fund invests in various sectors, such as communications, utilities, energy, industrial, technology, and others.